Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Crucell, Harvard's Adenoviral Vector Work Gets $19M Grant

Aug. 2, 2005

By Jennifer Boggs

Crucell NV's ongoing collaboration with Harvard Medical School to develop vaccine technology using adenovirus-based vectors received a $19.2 million boost from the National Institutes of Health. (BioWorld Today)

Crucell, Harvard's Adenoviral Vector Work Gets $19M Grant

Aug. 2, 2005

By Jennifer Boggs

Crucell NV's ongoing collaboration with Harvard Medical School to develop vaccine technology using adenovirus-based vectors received a $19.2 million boost from the National Institutes of Health. (BioWorld Today)

Advancis Cuts Staff After Amoxicillin Pulsys Misses

Aug. 1, 2005

By Jennifer Boggs

Indevus In-Licenses Nebido To Complement Sanctura

Aug. 1, 2005

By Jennifer Boggs

Advancis Cuts Staff After Amoxicillin Pulsys Misses

Aug. 1, 2005

By Jennifer Boggs

Indevus In-Licenses Nebido To Complement Sanctura

Aug. 1, 2005

By Jennifer Boggs

Cerovive NDA Delayed: More Patients Needed For Phase III

July 29, 2005

By Jennifer Boggs

Cerovive NDA Delayed: More Patients Needed For Phase III

July 29, 2005

By Jennifer Boggs

Changes to delay EPIX trial of blood clot imaging agent

July 28, 2005

By Jennifer Boggs

Biogen Idec: Strong Sales Boost Earnings, Tysabri Data Looming

July 28, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 18, 2025.
New research solves mystery of sex differences in acute kidney injury
BioWorld Science
German researchers have cracked the decades-long mystery of why males are more susceptible to acute kidney injury than females, demonstrating that estrogen has a...
Superluminal joins a $1.3B deal with series A backer Lilly
Deals and M&A
Superluminal Medicines Inc. and Eli Lilly and Co. are collaborating in a deal to develop cardiometabolic disease and obesity therapies by aiming at undisclosed G...
Neuroone's Onerf wins FDA clearance for trigeminal nerve ablation
BioWorld MedTech
Neuroone Medical Technologies Corp. expanded into treatment of chronic pain with a new U.S. FDA clearance for use of its Onerf system to treat trigeminal nerve...